Matrix Biomed, Inc.
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| MBM-01 (Tempol) for the Treatment of Ataxia Telangiectasia (NCT04887311) | Matrix Biomed, Inc. | 2021-07-01 |
| MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM) (NCT04874506) | Matrix Biomed, Inc. | 2021-06-01 |
| MBM-02 (Tempol) for the Treatment of Biochemical Recurrent Prostate Cancer (NCT04876755) | Matrix Biomed, Inc. | 2021-05-30 |
| Treatment of Radiation and Cisplatin Induced Toxicities with Tempol (NCT03480971) | Matrix Biomed, Inc. | 2019-05-13 |
| Treatment of Metastatic Cancer in Terminally Diagnosed Patients (NCT05491928) | Matrix Biomed, Inc. | |
| A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate Cancer (NCT04337099) | Matrix Biomed, Inc. |
Track Matrix Biomed, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.